Mood disorders are among the most prevalent and debilitating mental conditions in worldwide populations. Non-adherence to treatment recommendations may have serious consequences for patients with mood disorders. There are several methods to show whether the patient cooperates with the doctor and follows his recommendations, or whether he or she skips the prescribed doses of medications. These include objective methods, such as detecting the drug in the blood, urine or saliva by analysis or special markers, pill counting, electronic monitoring, and an electronic record of filled prescriptions. Subjective methods involve assessment of the patient, medical staff, and those in the patient’s immediate environment. The most commonly used subjective methods are an interview, filling out a questionnaire, and assessment by health care professionals and the patient’s relatives The problem arises when the patient inadvertently skips medications, which makes it difficult to assess adherence. This may be due to the severity of the disease and poorer cognitive function, and sometimes a change in daily routine. The aim of the study was to identify factors influencing life satisfaction, disease acceptance and therapeutic adherence among people with mood disorders. This survey-based study included 103 people with mood disorders. It was performed using the author questionnaire, and standardized research tools, namely: the Adherence to Refills and Medication Scale (ARMS), the Acceptance of Illness Scale (AIS), the Beck Depression Inventory (BDI), and the Satisfaction with Life Scale (SWLS). The level of life satisfaction decreased with an increase in the severity of depressive symptoms (βstd. = -0.665, p < 0.001). Mood disorder patients with more severe depressive symptoms had significantly higher scores on the adherence scale (βstd. = 0.290, p = 0.003). Patients with higher levels of depressive symptoms showed a lower level of acceptance of the disease (βstd. = -0.215, p < 0.001). 1. The dosage of medications taken, and the severity of depressive symptoms determine life satisfaction of people with mood disorders. 2. Respondents with greater severity of depressive symptoms scored higher on the adherence scale, which means that they were more likely to be non-adherent to treatment recommendations. The type of mood disorder may affect patient adherence. Subjects with bipolar disorder showed higher and those with anxiety-depressive disorder—lower adherence than patients with depression. 3. Subjects with more severe depressive symptoms showed a lower degree of acceptance of the disease. None Declared

IntroductionNon-adherence to treatment recommendations is a significant problem, as it contributes to the progression of the disease and to the exacerbation of distressing symptoms. Failure to cope with the disease and elevated levels of stress, in turn, influence the choice of strategy for coping with a difficult situation, and thus adherence to recommendations.ObjectivesThe purpose of our study was to evaluate the impact of the subjects’ stress coping styles on therapeutic adherence, life satisfaction, disease acceptance and quality of life (QoL) in people with mood disorders.MethodsThis survey-based study included 102 respondents diagnosed with mood disorders, living in the West Pomeranian Voivodeship. It was performed using the sociodemographic questionnaire and standardized tools: The Coping Inventory for Stressful Situations (CISS), The Satisfaction with Life Scale (SWLS), The Short Form-36 (SF-36) Health Survey, The Adherence to Refills and Medication Scale (ARMS), and The Acceptance of Illness Scale (AIS).ResultsSome 47.06% of the respondents suffered from depressive disorders, while 34.31% had depression or mixed anxiety disorder. Patients who made greater use of an emotion-focused style were found to have significantly lower life satisfaction than other patients. Moreover, this style was related to such SF-36 domains as general health, social functioning, role emotional, vitality, and mental health, as well as to physical component summary (PCS) and mental component summary (MCS).ConclusionTreatment non-adherence is a serious challenge in the treatment of patients with mood disorders. Individuals who do not adequately follow treatment recommendations often resort to alternative activities as a mechanism for coping with difficult situations. Patients who predominantly adopt an emotion-oriented coping style tend to experience lower life satisfaction and greater difficulty accepting their condition compared to their peers. Conversely, patients who adopt a task-oriented coping style report better quality of life than those who rely on emotion-oriented coping or alternative activities.

Background: Mood disorders are among the most prevalent and debilitating mental conditions in worldwide populations. The aim of this study was to identify the factors influencing life satisfaction, disease acceptance, and therapeutic adherence among people with mood disorders. Methods: This survey-based study included 103 people with mood disorders. It was performed using the author questionnaire, and standardized research tools, namely the Adherence to Refills and Medication Scale (ARMS), the Acceptance of Illness Scale (AIS), the Beck Depression Inventory (BDI), and the Satisfaction with Life Scale (SWLS). Results: The level of life satisfaction decreased with the increase in the severity of the depressive symptoms (SE = -0.665, p < 0.001). Mood disorder patients with more severe depressive symptoms had significantly higher scores on the adherence scale (SE = 0.290, p = 0.003). The patients with higher levels of depressive symptoms showed a lower level of acceptance of the disease. Conclusions: 1. The dosage of medications taken, and the severity of the depressive symptoms determine life satisfaction of people with mood disorders. 2. The respondents with a greater severity of depressive symptoms scored higher on the adherence scale, which means that they were more likely to be non-adherent to the treatment recommendations. The type of mood disorder may affect patient adherence. The subjects with bipolar disorder showed higher adherence and those with anxiety-depressive disorder showed a lower adherence than the patients with depression. 3. The subjects with more severe depressive symptoms showed a lower degree of acceptance of the disease.

Introduction: Crohn’s disease is a chronic condition that affects the functioning and life of the patients. Quality of life of patients affected by the disease is of particular importance because it allows better functioning in all dimensions of life. It is essential to identify the numerous factors that affect the patients’ of quality of life. Aim of the research: To search for medical factors that influence the quality of life of patients affected by Crohn’s disease. Material and methods: The study was conducted using a diagnostic survey. The study group comprised 100 adult patients with Crohn’s disease hospitalised in the Gastroenterology Clinic of the Autonomous Public Hospital Complex No.1 of Pomeranian Medical University in Szczecin. The study was conducted in accordance with the Declaration of Helsinki. The standardised quality of life questionnaire SF-36v2 and an original questionnaire were used. The collected data were statistically analysed. Results: The analysis demonstrated a statistically significant effect of disease duration on quality of life as regards social functioning and mental health (p < 0.05). The course of the disease was found to affect all domains and dimensions of quality of life (p < 0.05). Treatment modality had a statistically significant influence only on the domain of physical functioning (p < 0.05). The number of hospitalisations in the year preceding the study was found to have a significant effect only on particular domains (p < 0.05). Conclusions: The course of the disease had the most significant effect on the quality of life of patients with Crohn’s disease. Other significant factors are determining the tailored method of treatment and disease duration.

Aim of the study: Crohn’s disease belongs to the group of non-specific inflammatory bowel diseases. Due to its chronic nature, incurability, and the risk of various complications, this disorder imposes a huge bio-psycho-social burden on patients. The aim of the study was to analyse the relationship between the quality of life and the acceptance of illness in patients suffering from Crohn’s disease. Material and methods: The study involved 100 adult patients with Crohn’s disease hospitalised in the Department of Gastroenterology SPSK No. 1 of the PUM in Szczecin. A diagnostic survey method was used for the research using standardised research tools: SF-36v2, Acceptance of Illness Scale, and the authors’ own questionnaire. Results: The highest quality of health was achieved by patients in physical functioning (78.50) and the lowest in vitality (42.25), whereas the largest group of patients demonstrated a moderate acceptance of illness (49%). A statistically significant positive correlation between the quality of life and acceptance of illness was found for all domains (p < 0.001) except for the social functioning domain. Conclusions: A higher level of acceptance of illness has a positive impact on the quality of life of patients in the bio-psycho-social sphere. Patients who are characterised by a higher degree of acceptance of illness show a higher level of adaptation to life with the disease and a better quality of life.

ABSTRACTIntroduction: Multiple sclerosis is a chronic autoimmune disease, usually occurring between 20 and 40 years of age, where central nervous system demyelination occurs.Materials and methods: After establishing cooperation with 5 departments of the Polish Society of Multiple Sclerosis in Poland and the Rehabilitation Center in Krakow, 179 questionnaires were obtained from people with multiple sclerosis. The study used diagnostic survey methods and standardized Quality of Life Questionnaire Short Form 36.Results: The largest group were women, 72.63%, the average disease duration was 13.18 years, the lowest quality of life values were the domain of social functioning 3.23 ±2.0 points, pain sensation 4.44 ±2.7 points and limitations resulting from the emotional state 8.02 ±6.8 points. A statistically significant correlation was found between age, sex, duration of the disease (p < 0.05) in selected domains and dimensions. The results of the analysis showed statistically significant correlations between the symptoms of the disease and the quality of life assessment in individual categories and dimensions (p < 0.05).Conclusions: 1. Assessment of the quality of life by patients with multiple sclerosis in particular domains is very diverse, with the lowest ranked domain concerning social contacts, the highest domain physical functioning and physical dimension. 2. Elderly people and those who have been suffering from multiple sclerosis for longer have rated their quality of life worse than younger and shorter suffering people. This applies mainly to the domain of physical functioning and the physical dimension. This is probably due to the disease process and adaptation to the changing conditions dictated by the progressive disease. 3. The severity of disease symptoms in people with multiple sclerosis is associated with a decrease in the quality of life of these people.